surmount-osa trial tirzepatide results VisualAbstract: Improved Outcomes in Patients with Obstructive Sleep Apnea and Obesity Tirzepatide SURMOUNTs obstructive sleep apnea,

Do not us e the sam e injection sit e f or eac h injec tion

You should think of this medication as a way to kick-start and accelerate weight loss

Cel Oncol (Dordr) 40, 199208

Instead, it may be connected to broader shifts like lower food intake, fatigue, or other side effects

Generally, the treatment starts with a dose of 25mg daily and then gradually increases weekly by 25 50mg

Because retatrutide is still investigational, important unanswered questions remain about long-term cardiovascular effects, durability of weight loss, ongoing tolerability, and safety across broader patient populations, which is one reason reputable clinics, including Relive Health centers nationwide, are not offering retatrutide at this time